Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Korro Bio disclosed the grant of a non-statutory stock option to one newly hired employee under Nasdaq Listing Rule 5635(c)(4). The grant covers 3,000 shares with an exercise price of $11.20, matching the closing price on the grant date of May 13, 2026.
Key figures
- Exercise price
- 11.2
- Shares granted
- 3000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.